Interspecies allometric scaling. Part I: Prediction of clearance in large animals

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 5, 2006, Pages 415-423

  Mahmood, I ^a   Martinez, M ^b   Hunter, R P ^c  

^a Center for Drug Evaluation and Research   (United States)

^b Center for Veterinary Medicine   (United States)

^c ELANCO ANIMAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CEFOPERAZONE; ENROFLOXACIN; FLUCONAZOLE; FLUNIXIN; FUROSEMIDE; GENTAMICIN; PHENAZONE; PROPRANOLOL DERIVATIVE; SULFADIMIDINE; THEOPHYLLINE; THIAMPHENICOL;

ALLOMETRY; ARTICLE; BODY SIZE; DRUG CLEARANCE; DRUG SAFETY; DRUG WITHDRAWAL; OPTIMAL DRUG DOSE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SPECIES COMPARISON; TREATMENT RESPONSE;

ANIMALS; BODY WEIGHT; HUMANS; METABOLIC CLEARANCE RATE; PHARMACOKINETICS; REGRESSION ANALYSIS; SPECIES SPECIFICITY;

ANIMALIA; CAMELIDAE; ELEPHANTIDAE;

EID: 33748363499     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00786.x     Document Type: Article

References (49)

1. Ali, B.H., Wong, Y.C., Alhadrami, G.A., Charles, B.G. & Bashir, A.K. (1998) Plasma pharmacokinetics of intravenous and intramuscular furosemide in the camel (Camelus dromedarius). Research in Veterinary Science, 64, 69-72.
2. Aramaki, S., Mori, M., Nakata, M., Shinohara, A. & Koizumi, T. (2000) Pharmacokinetics of propranolol and its metabolites in horses after intravenous or oral administration. Biological and Pharmaceutical Bulletin, 23, 1333-1340.
3. Bachmann, K. (1989) Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species. Journal of Applied Toxicology, 9, 331-338.
4. Balani, S.K., Zhu, T., Yang, T.J., Liu, Z., He, B. & Lee, F.W. (2002) Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys. Drug Metabolism and Disposition, 30, 1059-1062.
5. Ben-Zvi, Z., Rubin, M., Van Creveld, C. & Yagil, R. (1995) Antipyrine disposition in the dehydrated camel. Journal of Veterinary Pharmacology and Therapeutics, 18, 137-140.
6. Bonati, M., Latini, R., Tognoni, G., Young, J.F. & Garattini, S. (1984) Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse. Drug Metabolism Review, 15, 1355-1383.
7. Boxenbaum, H. & Dilea, C. (1995) First-time-in-human dose selection: allometric thoughts and perspectives. Journal of Clinical Pharmacolology, 35, 957-966.
8. Boxenbaum, H. & Fertig, J.B. (1984) Scaling of antipyrine intrinsic clearance of unbound drug on 15 mammalian species. European Journal of Drug Metabolism and Pharmacokinetics, 9, 177-183.
9. Bregante, M.A., Saez, P., Aramayona, J.J., Fraile, L., Garcia, M.A. & Solans, C. (1999) Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. American Journal of Veterinary Research, 60, 1111-1116.
10. Castells, G., Capece, B.P., Perez, F., Marti, G., Arboix, M. & Cristofol, C. (2001) Allometric analysis of thiamphenicol disposition among seven mammalian species. Journal of Veterinary Pharmacology and Therapeutics, 24, 193-197.
11. Cheng, Z., McKeller, Q. & Nolan, A. (1998) Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep. Journal of Veterinary Pharmacology and Therapeutics, 21, 315-321.
12. Coakley, M., Peck, K.E., Taylor, T.S., Matthews, N.S. & Mealey, K.L. (1999) Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses. American Journal of Veterinary Research, 60, 1441-1444.
13. Doyle, E., Chasseaud, L.F. & Miller, J.N. (1982) Comparative pharmacokinetics of frusemide in female rhesus monkeys, cynomolgus monkeys and baboons. Comparative Biochemistry Physiology C, 71C, 89-93.
14. Dyke, T.M., Sams, R.A. & Hinchcliff, K.W. (1998) Antipyrine pharmacokinetics and urinary excretion in female horses. American Journal of Veterinary Research, 59, 280-285.
15. Elsheikh, H.A., Ali, B.H., Homeida, A.M., Hassan, T. & Hapke, H.J. (1991) Pharmacokinetics of antipyrine and sulphadimidine (sulfamethazine) in camels, sheep and goats. Journal of Veterinary Pharmacology and Therapeutics, 14, 269-275.
16. Elsheikh, H.A., Ali, B.H., Zahurin, M., Mustafa, A.M., Alhadrami, G. & Bashir, A.K. (2001) Comparative pharmacokinetics of theophylline in camels (Camelus dromedarius) and goats (Caprus hircus). Journal of Veterinary Medical A Physiology and Pathology Clinical Medicine, 48, 581-586.
17. Ensminger, M.E., Oldfield, J.E. & Heinemann, W.W. (1990) Feeds and Nutrition, p. 53. Ensminger Publishing Company, Clovis, CA.
18. Evans, G.H., Nies, A.S. & Shand, D.G. (1973) The disposition of propranolol III. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog, and rat. Journal of Pharmacology and Experimental Therapeutics, 186, 114-122.
19. Gascon, A.R., Calvo, B., Hernandez, R.M., Dominguez-Gil, A. & Pedraz, J.L. (1994) Interspecies scaling of cimetidine-theophylline pharmacokinetic interaction: interspecies scaling in pharmacokinetic interactions. Pharmaceutical Research, 11, 945-950.
20. Gavrielli, R., Yagil, R., Ziv, G., Creveld, C.V. & Glickman, A. (1995) Effect of water deprivation on the disposition kinetics of enrofloxacin in camels. Journal of Veterinary Pharmacology and Therapeutics, 18, 333-339.
21. Haines, G.R., Brown, M.P., Gronwall, R.R. & Merritt, K.A. (2000) Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares. Canadian Journal of Veterinary Research, 64, 171-177.
22. Hardie, E.M., Hardee, G.E. & Rawlings, C.A. (1985) Pharmacokinetics of flunixin meglumine in dogs. American Journal of Veterinary Research, 46, 235-237.
23. Hunter, R.P., Isaza, R. & Koch, D.E. (2003) Oral bioavailability and pharmacokinetic characteristics of ketoprofen enantiomers after oral and intravenous administration in Asian elephants (Elephas maximus). American Journal of Veterinary Research, 64, 109-114.
24. Ingvast-Larsson, C., Paalzow, G., Paalzow, L., Ottosson, T., Lindholm, A. & Appelgren, L.E. (1985) Pharmacokinetic studies of theophylline in horses. Journal of Veterinary Pharmacology and Therapeutics, 8, 76-81.
25. Isaza, R. & Hunter, R.P. (2004) Drug delivery to captive Asian Elephants - treating goliath. Current Drug Delivery, 1, 291-298.
26. Jezequel, S.G. (1994) Fluconazole: interspecies scaling and allometric relationships of pharmacokinetic properties. Journal of Pharmacy and Pharmacology, 46, 196-199.
27. Kung, K., Riond, J.L. & Wanner, M. (1993) Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462-468.
28. Landoni, M.F., Cunningham, F.M. & Lees, P. (1995) Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling. American Journal of Veterinary Research, 56, 786-794.
29. Latimer, F.G., Colitz, C.M., Campbell, N.B. & Papich, M.G. (2001) Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses. American Journal of Veterinary Research, 62, 1606-1611.
30. Lave, T., Dupin, S., Schmitt, C., Chou, R.C., Jaeck, D. & Coassolo, P. (1997) Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. Journal of Pharmaceutical Sciences, 86, 584-590.
31. Lees, P. & Taylor, P.M. (1991) Pharmacodynamics and pharmacokinetics of flunixin in the cat. British Veterinary Journal, 147, 298-305.
32. MacGregor, R. (1980) The Structure of the Meat Animals. A Guide to their Anatomy and Physiology. 225 pp. Technical Press, Oxford.
33. Mahmood, I. (2005) Interspecies Pharmacokinetic Scaling: Principles and Application of Allometric Scaling. 393 pp. Pine House Publishers, Rockville, MD.
34. Mahmood, I. & Balian, J.D. (1996) Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica, 26, 887-895.
35. Martin-Jimenez, T. & Riviere, J.E. (2001) Mixed effects modeling of the disposition of gentamicin across domestic animal species. Journal of Veterinary Pharmacology and Therapeutics, 24, 321-332.
36. Martinez, M.N. (2006) Interspecies differences in physiology and pharmacology: extrapolating preclinical data to human populations. In: Preclinical Drug Development Eds Rogge, M. & Taft, D. pp. 11-66. Marcel Dekker, New York (in press).
37. McNamara, D.R., Nafziger, A.N., Menhinick, A.M. & Bertino, J.S., Jr (2001) A dose-ranging study of gentamicin pharmacokinetics: implications for extended interval aminoglycoside therapy. Journal of Clinical Pharmacology, 41, 374-377.
38. Nouws, J.F., Firth, E.C., Vree, T.B. & Baakman, M. (1987) Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses. American Journal of Veterinary Research, 48, 392-402.
39. Obach, R.S., Baxter, J.G., Liston, T.E., Silber, B.M., Jones, B.C., Macintyre, F., Rance, D.J. & Wastall, P. (1997) The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism. Journal of Pharmacology and Experimental Therapeutics, 283, 46-58.
40. Peck, K., Mealey, K.L., Matthews, N.S. & Taylor, T.S. (1997) Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys. American Journal of Veterinary Research, 58, 881-884.
41. Riffat, S., Nawaz, M. & Zia-Ur-Rehman (1982) Pharmacokinetics of sulphadimidine in normal and febrile dogs. Journal of Veterinary Pharmacology and Therapeutics, 5, 131-135.
42. Sacher, G.A. (1959) Relation of Lifespan to Brain Weight and Body Weight in Mammals. 115 pp. Ciba Foundation Colloquium, Ageing, Basilea.
43. Sawada, Y., Hanano, M., Sugiyama, Y. & Iga, T. (1984) Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals. Journal of Pharmacokinetics and Biopharmaceutics, 12, 241-261.
44. Schmidt, M. (1986) Elephants (Proboscidea). In Zoo & Wild Animal Medicine, 2nd edn. Ed. Fowler, M.E.. 883 pp. Sauders, Philadelphia, PA.
45. Soraci, A.L., Mestorino, O.N. & Errecalde, J.O. (1996) Pharmacokinetics of cefoperazone in horses. Journal of Veterinary Pharmacology and Therapeutics, 19, 39-43.
46. Tanira, M.O., Ali, B.H. & Bashir, A.K. (1997) Effect of endotoxin on gentamicin pharmacokinetics in old and young adult rats. Life Sciences, 60, 413-424.
47. Wasfi, I.A., Boni, N.S., Abdel Hadi, A., Elghazali, M., Zorob, O., Alkatheeri, N.A. & Barezaiq, I.M. (1998) Pharmacokinetics, metabolism and urinary detection time of flunixin after intravenous administration in camels. Journal of Veterinary Pharmacology and Therapeutics, 21, 203-208.
48. Wasfi, I.A., Boni, N.S., Elghazali, M., Abdel Hadi, A.A., Almuhrami, A.M., Barezaig, I.M. & Alkatheeri, N.A. (2000) The pharmacokinetics, metabolism and urinary detection time of caffeine in camels. Research in Veterinary Science, 69, 69-74.
49. Witkamp, R.F., Yun, H.I., van't Klooster, G.A., van Mosel, J.F., van Mosel, M., Ensink, J.M., Noordhoek, J. & van Miert, A.S. (1992) Comparative aspects and sex differentiation of plasma sulfamethazine elimination and metabolite formation in rats, rabbits, dwarf goats, and cattle. American Journal of Veterinary Research, 53, 1830-1835.